Drug Approval | April 22, 2026
US FDA okays Merck's new once-daily HIV pill
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
The MAST trial is designed to test whether a single dose of pre-emptive, orally administered EBX-102-02 can protect and restore microbial diversity during transplantation
The company says those insights can power advanced analytics and real-world evidence (RWE), helping researchers improve trial design, study feasibility, and recruitment strategies
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The new functionality complements Parse’s existing Evercode immune products
India in the Changing Landscape of Life-Sciences Research & Development
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
